Some estimates had projected Myrbetriq to contribute close to $30 million each to the quarterly sales of both the pharma companies, a note by Equirus said, suggesting a possible financial penalty as well..
Politics
Bitter pill for Lupin, Zydus Life shares, patent case over Myrbetriq lost in US Federal Court
